focus -WSS

focus

author：comprehensive 2025-09-28 19:25:46 - browse：6674

Portrait of R. Shawn Martin -- health coverage from STAT — R. Shawn Martin, the CEO of the American Academy of Family Physicians Courtesy American Academy of Family Physicians

In ten years, the United States could be short as many as 48,000 primary care doctors. The specialty is underpaid, to a point that doctors are lobbying Medicare to pay it extra. Even medical residents who chose the specialty are leaving primary care; some 45% of residents who planned to be generalists changed their mind during their residencies.

But R. Shawn Martin, the CEO of the American Academy of Family Physicians, the specialty trade group, isn’t worried.

“I’ve been around this and at this a long time and family medicine and primary care’s obituary has been written many times in my 25-plus years of doing this work,” he said with a laugh. “This isn’t the first time that primary care has been dying or fading away.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： Heat wave can put hearts into ‘oxygen debt,' lab experiment shows

WSS

Telehealth options flood the market as retailers push virtual care

FDA reviewers ask if approval of Lilly’s Alzheimer’s drug should be restricted

The pink breast cancer awareness ribbon needs a redesign

Readers discuss the intersection of pregnancy and addiction

Pharma companies must ensure equitable access to obesity drugs

Statins may not be needed by millions of people, study suggests

hotspot

focus

focus

Medical records are filled with copy

Study: Why relieving medical debt did not improve financial outcomes

Cancer drug shortages should be causing more outrage

STAT Virtual Event: ASCO Recap, Live!

Jerome Adams on the need for new antivirals for Covid

Coercive sterilizations revealed by STAT prompt outrage

Bright Health sells Medicare Advantage business to Molina

Cassava reveals details — and problems — with Alzheimer's study

Medical records are filled with copy

Lilly's Alzheimer's drug donanemab backed by FDA advisers

focus

Curing rare childhood diseases will falter unless Congress steps up

Teladoc has a new CEO, but challenges remain the same

Emergency medicine has repudiated 'excited delirium.' Now what?

Readout Newsletter: New research from Sanofi, Regeneron, etc.

Readout Newsletter: What happened with Sarepta's Duchenne data

Medical device trials still don't enroll enough women, study finds

knowledge

hotspot

focus

explore